Navigation Links
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
Date:9/10/2008

ses on kinases, especially in the fields of oncology, inflammation and metabolic diseases. Despite this level of interest and research, only 8 small molecule kinase inhibitors have so far reached the market, all of them targeting oncology indications.

For further information please contact:

Cellzome Enquiries:

Cellzome Inc., Cellzome Limited and Cellzome AG

Tim Edwards

Chief Executive Officer

+49(0)6221-137 57-100

press@cellzome.com

Media Contact for Cellzome

The Hogarth Partnership

Sarah MacLeod

+44(0)207-357-9477

smacleod@hogarthpr.co.uk

GSK Enquiries:

UK Media enquiries: Philip Thomson +44(0)20-8047-5502

Claire Brough +44(0)20-8047-5502

Alice Hunt +44(0)20-8047-5502

Gwenan White +44(0)20-8047-5502

US Media enquiries Nancy Pekarek +1-215-751-7709

Mary Anne Rhyne +1-919-483-2839

Sarah Alspach +1-215-751-7709

European Analyst/Investor David Mawdsley +44(0)20-8047-5564

enquiries:

Sally Ferguson +44(0)20-8047-5543

Gary Davies +44(0)20-8047-5503

US Analyst/ Investor

enquiries: Frank Murdolo +1-215-751-7002

Tom Curry +1-215-751-5419


'/>"/>
SOURCE Cellzome Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
2. GlaxoSmithKline To Post Quarterly US Grants Report
3. GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
4. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
5. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
6. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
7. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
8. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
9. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
10. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
11. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Calif. , Oct. 30, 2014  Ardelyx, ... biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic ... quarter 2014 financial results on Thursday, November 6, ... will host a live conference call and webcast ... results and provide a business update. ...
(Date:10/30/2014)... Rancho BioSciences , the scientific ... curated public data source TCGA for several ... data is now available for other oncology groups. ... internal data sources for their Pharma, Government and academic ... data that becomes more easily accessible. Rancho advises ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Grace Century portfolio ... James A. Manganello, Chairman of the Board, to the ... The appointment was made by the Ministry of Health ... 24th, 2014. , More than a year after ... Bill , Prime Minister Perry Christie said the government has ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Rancho BioSciences Manually Curated TCGA Data Sets Available 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3CU Denver study says upgrading infrastructure could reduce flood damage 2
... 20 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... Inc. (Ibis), has been awarded four new,government contracts ... detection,and identification of microbial threat agents for biodefense ... of Homeland Security,Science and Technology Directorate (DHS-S&T) and ...
... Retrieving material for composting from open dumps across the ... mountains of waste, according to researchers in India, writing ... Technology and Management. , These days we in the ... kitchen waste. However, not everyone has a compost bin ...
... Coulter,Inc. (NYSE: BEC ), a leading developer, ... innovate complex biomedical testing,announced today that Charles Slacik, ... will present at the 2007 UBS Global,Life Sciences ... p.m.,(EDT). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The ...
Cached Biology Technology:Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4Landfill mining reduces environmental impact of growing waste 2Beckman Coulter to Present at the UBS Global Life Sciences Conference 2
(Date:10/28/2014)... awards to expand the Office of Rare Diseases ... Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical Research ... at 22 consortia will work with 98 patient ... new treatments for patients with rare diseases. The ... fiscal 2014 funding from NIH. , Rett syndrome, ...
(Date:10/27/2014)... a scientific one-two punch with a pair of papers ... sticky ends. , Collagen is the most common protein ... fibrous tissues that support cells and hold organs together. ... for tissue engineering and cosmetic and reconstructive medicine. , ... synthetic collagen for a decade, teasing out the details ...
(Date:10/27/2014)... Recent breakthroughs may pave the way for vaccines ... helminths. These flatworms, including tapeworms that cause hydatid ... (schistosomes), infect more than 300 million people and ... due to chronic illness and death each year. ... microbiology, immunology, and tropical medicine, and scientific director ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3GW researcher adapting breakthrough technologies to combat parasitic worm infections 2
... of hatchery-raised young salmonids are released into Swedish rivers ... Butthese fish generally survive poorly in the wild. Researchers ... young fish get too crowded at the hatchery. ... million euro to a Swedish/Nordic research project. The goal ...
... of University of Kansas researchers working with Chinese colleagues have ... years ago in China. This is the first report of ... "This thing is a venomous bird for all intents and ... paleontology at the Natural History Museum and Biodiversity Institute. "It ...
... drug-resistant form of the deadly H5N1 avian influenza is a nightmare ... study published this week (Dec. 21) in the Proceedings of ... a new compound, one on the threshold of final testing in ... than the antiviral drug best known by the trade name Tamiflu. ...
Cached Biology News:Hatchery-raised salmon too crowded 2Poisonous prehistoric 'raptor' discovered by research team from Kansas and China 2Compound found to safely counter deadly bird flu 2
Rb anti-Occludin (C-term GST)...
... miRNA Isolation Traditional mRNA isolation procedures ... can result in the loss of substantial ... Isolation Kit purifies all RNA species (including ... an enrichment procedure included in the mirVana ...
Rabbit polyclonal to EDG2 ( Abpromise for all tested applications). entrezGeneID: 1902 SwissProtID: Q92633...
ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
Biology Products: